Extracorporeal artificial liver support systems in the management of intractable cholestatic pruritus

Liver International

Volumn 31, Issue SUPPL. 3, 2011, Pages 31-33

  Fuhrmann, Valentin ^a   Drolz, Andreas ^a   Trauner, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cholestasis; MARS; Plasmapheresis; Prometheus; Pruritus

Indexed keywords

BILE ACID; BILE ACID SEQUESTRANT; COLESTIPOL; COLESTYRAMINE; LYSOPHOSPHATIDIC ACID; RIFAMPICIN; SERTRALINE; URSODEOXYCHOLIC ACID;

BILIARY TRACT DISEASE; HUMAN; HYPOTHESIS; INTRACTABLE CHOLESTATIC PRURITUS; LIVER SUPPORT; LIVER TRANSPLANTATION; PATHOGENESIS; PLASMAPHERESIS; PRURITUS; REVIEW; VISUAL ANALOG SCALE;

CHOLESTASIS; CHOLESTYRAMINE RESIN; HUMANS; LYSOPHOSPHOLIPIDS; OPIOID PEPTIDES; PLASMAPHERESIS; PRURITUS; RENAL DIALYSIS; RIFAMPIN; SERTRALINE; SORPTION DETOXIFICATION; URSODEOXYCHOLIC ACID;

EID: 79961189605     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02584.x     Document Type: Review

References (14)

1. Kremer AE, Beuers U, Oude-Elferink R, et al. Pathogenesis and treatment of pruritus in cholestasis. Drugs 2008; 68: 2163-8.
2. Beuers U, Boherg KM, Chapman RW, et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-67.
3. Lindor KD, Gershwin ME, Poupon R, et al. AASLD practice guideline: primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
4. Zitat Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690-4.
5. Beuers U, Gerken G, Pusl T. Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis. Hepatology 2006; 44: 280-1.
6. Ghent CN, Bloomer JR, Klatskin G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus. Gastroenterology 1977; 73: 1125-30.
7. Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatide acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010; 139: 1008-18.
8. Silveira MG, Brunt EM, Heathcote J, et al. AASLD endpoints conference: design and endpoints for clinical trials in primar biliary cirrhosis. Hepatology 2010; 52: 349-59.
9. ®). Scand J Gastroenterol 2006; 41: 1212-7.
10. Pares A, Herrera M, Aviles J, et al. treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. J Hepatol 2010; 53: 307-12.
11. Doria C, Mandala L, Smith J, et al. Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. Liver Transpl 2003; 9: 437-43.
12. Bellmann R, Graziadei I, Feistritzer C, et al. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl 2004; 10: 107-14.
13. Cohen LB, Ambinder EP, Wolke AM, et al. Role of plasmapheresis in primary biliary cirrhosis. Gut 1985; 26: 291-4.
14. Alallam A, Barth D, Heathcote J. Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports. Can J Gastroenterol 2008; 22: 505-7.